Tom Home Page

Tom Home Page

Our Shielded-Cell and Immunotherapy Pairs represent a fundamentally new approach to cellular therapy. We believe our technology platform has the potential to significantly improve HSC transplant, and will one day allow it to be given as an outpatient procedure in some...
Lukas Home Page

Lukas Home Page

We have the ability to specifically edit a cell surface receptor to completely prevent antibody binding while keeping the receptor fully functional. Instead of removing a target entirely, this type of epitope editing has the potential to allow the shielding of any...